Quick links
Categories
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
EU Regulation (EC) No 726/2004]
Consolidated text: Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Union procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (Text with EEA relevance)Text with EEA relevance
All
This is some text inside of a div block.
This is some text inside of a div block.
EU Regulation (EC) No 726/2004]
Consolidated text: Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Union procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (Text with EEA relevance)Text with EEA relevance
EU Pharmaceutical legislation
This is some text inside of a div block.
This is some text inside of a div block.
EU Pharmaceutical legislation[Directive 2001/83/EC1)
Consolidated text: Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use
All
This is some text inside of a div block.
This is some text inside of a div block.
EU Pharmaceutical legislation[Directive 2001/83/EC1)
Consolidated text: Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use
EU Pharmaceutical legislation
This is some text inside of a div block.
This is some text inside of a div block.
EU Pharma strategy
Adopted on 25 November 2020, the Pharmaceutical Strategy for EuropeEN••• (reader-friendly versionEN•••) aims at creating a future proof regulatory framework and at supporting the industry in promoting research and technologies that reach patients to fulfil their therapeutic needs while addressing market failures. It will also consider the weaknesses exposed by the coronavirus pandemic and take appropriate actions to strengthen the system.
All
This is some text inside of a div block.
This is some text inside of a div block.
EU Pharma strategy
Adopted on 25 November 2020, the Pharmaceutical Strategy for EuropeEN••• (reader-friendly versionEN•••) aims at creating a future proof regulatory framework and at supporting the industry in promoting research and technologies that reach patients to fulfil their therapeutic needs while addressing market failures. It will also consider the weaknesses exposed by the coronavirus pandemic and take appropriate actions to strengthen the system.
EU Pharmaceutical legislation
This is some text inside of a div block.
This is some text inside of a div block.
European Commission: Roadmap
The EU is launching a new strategy to improve and accelerate patients’ access to safe and affordable medicines and to support innovation in the EU pharmaceutical industry.
All
This is some text inside of a div block.
This is some text inside of a div block.
European Commission: Roadmap
The EU is launching a new strategy to improve and accelerate patients’ access to safe and affordable medicines and to support innovation in the EU pharmaceutical industry.
EU Pharmaceutical legislation
This is some text inside of a div block.
This is some text inside of a div block.
No results found